Video

Diabetes Friends

Exercise Stroke

PMS Linked to Smoking

Veggies Cosmetics

Scent Memories

Prescription Addiction

Wii Childrens Hosptial

Treanda Treats Rare Cancer

Posted on 03/20/2008, 15:19
By HealthDay News

Chemotherapy drug approved for chronic lymphocytic leukemia

THURSDAY, March 20 (HealthDay News) -- The Cephalon drug Treanda (bendamustine hydrochloride) has been approved by the U.S. Food and Drug Administration to treat chronic lymphocytic leukemia, a rare cancer that affects the blood and bone marrow.

CLL is expected to strike some 15,000 people in the United States this year, according to American Cancer Society estimates provided by the drugmaker.

In a trial of 301 patients that compared Treanda to an already approved chemotherapy drug, Treanda recipients had better response rates and longer progression-free survival, Cephalon said in a statement.

Treanda, expected to hit the U.S. market in April, works by damaging the DNA in cancer cells, causing these cells to die. Cephalon said the treatment was granted orphan drug status by the FDA, which offers companies exclusive marketing rights in return for drugs developed for rare diseases.

More information

The FDA has more information about this drug.

More news in Leukemia...

BigHealthTree.com Disclaimer

Bighealthtree.com Does Not Provide Medical Advice. This site, including the above information, is for informational purposes only and is not a substitute for professional medical or health advice. Always seek the advice of your physician or a qualified health or medical professional before starting any new treatment, changing existing treatment, or altering your current exercise and/or diet program. If you think you are having a medical emergency, call 911 (or the emergency services in your area) or your doctor immediately.

Rating: 2.7 / 5 (23 votes)